trending Market Intelligence /marketintelligence/en/news-insights/trending/_iL0mahgHUFEcaddN2MmDA2 content esgSubNav
In This List

Kalytera Therapeutics appoints CEO; COO resigns

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Kalytera Therapeutics appoints CEO; COO resigns

Kalytera Therapeutics Inc. appointed Robert Farrell permanent CEO.

Farrell had been serving as the company's interim CEO. He previously served Titan Pharmaceuticals Inc. as president and CEO and as CFO.

Additionally, Kalytera said David Bassa resigned as COO, while Pini Ben-Elazar resigned as a director.